Latest Financial Results News

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Global Masters Fund Limited (GFL) reported a robust 19.8% total return for FY2025, surpassing the MSCI World Index, while unveiling strategic moves to diversify beyond Berkshire Hathaway into private growth and regional quality funds.

Macquarie Technology Group unveiled ambitious plans to expand its AI-optimised data centre footprint, supported by a $450 million debt facility and strong growth across its cloud, government cybersecurity, and telecom divisions.

Comms Group Limited reported a steady FY25 with revenue growth and a strong start to FY26, driven by the recent TasmaNet acquisition and expanding global contracts. The company is targeting over $75 million in annualised revenue and aims to boost EBITDA to $9-10 million.

Comms Group reported robust FY25 results driven by domestic expansion, including the strategic acquisition of TasmaNet, and strong international growth in its Global and Wholesale division.

Atturra Limited reported a robust 24% increase in both revenue and underlying EBITDA for FY25, propelled by its cloud platform, AI innovations, and defence sector contracts. The company forecasts continued momentum into FY26 with ambitious growth targets.

IPD Group’s 2025 AGM reveals robust FY25 financial results driven by data centre and electrification sectors, alongside operational efficiencies and sustainability strides. The company signals continued momentum into FY26 with positive earnings guidance.

Whitefield Income Ltd reports robust first-quarter earnings and announces a $53 million capital raising via placement and a Share Purchase Plan, maintaining its focus on delivering steady, franked dividends.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Web Travel Group Limited has reported a robust first half of FY26 with a 22% increase in Total Transaction Value and EBITDA growth surpassing expectations, setting a confident tone for the year ahead.

WEB Travel Group has reported a stellar first half of FY26, posting a 22% rise in Total Transaction Value to $3.2 billion alongside strong EBITDA growth, signaling robust momentum ahead of full-year results.